SICP News

Genetic study questions HDL levels and the risk of MI

Heartwire News - 2 hours 41 min ago
The data, from a large-scale genetic analysis, throw cold water on the potential clinical benefits of raising HDL-cholesterol levels to reduce the risk of MI, say investigators.

For complete story visit theheart.org.
Categories: SICP News

FDA to review CV risk with azithromycin

Heartwire News - 3 hours 26 min ago
The agency recently revised the label of an oral-suspension version of the antibiotic to warn about reports of a potentially fatal heart arrhythmia.

For complete story visit theheart.org.
Categories: SICP News

NEJM: Common antibiotic linked to a few CV deaths, prompting FDA review

CardioVascular Business - 4 hours 27 min ago
There was a small absolute increase in cardiovascular deaths, which was most pronounced among patients with a high baseline risk of cardiovascular disease during the five-day administration of the antibiotic azithromycin (Zithromax, Pfizer) therapy. This study, which evaluated nearly 350,000 prescriptions of azithromycin and was published May 17 in the New England Journal of Medicine, has prompted an FDA review of its results.
Categories: SICP News

Simple risk score aids carotid-stenting decisions

Heartwire News - 7 hours 11 min ago
The factors determining a patient's risk during carotid surgery are fairly well-understood, but predicting the risk of carotid stenting patients has so far not been easy, so researchers mined the...

For complete story visit theheart.org.
Categories: SICP News

TAVI numbers rise in Europe as reimbursement, expertise expands

Heartwire News - 7 hours 26 min ago
New data unveiled at EuroPCR yesterday are offering a fresh snapshot of just how quickly the number of TAVI procedures is increasing in Europe and where these are taking place.

For complete story visit theheart.org.
Categories: SICP News

Statins benefit those at much lower CV risk

Heartwire News - Wed, 05/16/2012 - 18:30
Individual data from 175 000 patients show the benefits of statins greatly outweigh risks even in people with a 10-year risk of CV events of less than 10%. Authors of an accompanying "comment"...

For complete story visit theheart.org.
Categories: SICP News

Air pollutants mediate effects on heart health through inflammation and thrombosis

Heartwire News - Wed, 05/16/2012 - 17:15
The Chinese policy of restricting air-pollution emissions during the 2008 Olympic Games allowed researchers to assess the acute effects of air pollution, with the decrease in air pollution reducing...

For complete story visit theheart.org.
Categories: SICP News

Azithromycin may up chance of sudden cardiac death

Heartwire News - Wed, 05/16/2012 - 17:00
In an observational study, during a five-day course of azithromycin therapy, patients had a small, increased chance of dying from sudden cardiac death compared with patients taking amoxicillin. The...

For complete story visit theheart.org.
Categories: SICP News

So long, Plavix, what a ride! Clopidogrel patent expires

Heartwire News - Wed, 05/16/2012 - 14:45
Expiration of the clopidogrel patent draws a close to a "fascinating era" in cardiovascular medicine, say experts, having had its largest impact in the ACS and poststenting settings. Yet even as the...

For complete story visit theheart.org.
Categories: SICP News

Lancet: Bad news for HDL’s rep as the ‘good cholesterol’

CardioVascular Business - Wed, 05/16/2012 - 14:29
Being genetically predisposed to higher concentrations of high-density lipoprotein (HDL) cholesterol provides no protective benefits against MI, according to a meta-analysis published online May 17 in Lancet. The results put in question whether drugs designed to raise HDL levels will succeed in reducing the risk of heart attacks.
Categories: SICP News

COMFORTABLE-AMI: Bioerodable polymer DES trumps bare metal in STEMI

Heartwire News - Wed, 05/16/2012 - 10:50
The trial is the first randomized controlled trial to show a safety advantage of a DES, investigators say.

For complete story visit theheart.org.
Categories: SICP News

COMPARE II: Nobori biolimus stent matches everolimus stents in all-comers

Heartwire News - Wed, 05/16/2012 - 10:15
While equal to the market-leading Xience/Promus stents in terms of efficacy and safety, the Nobori failed to show an edge where many hope stents with bioerodable polymers will have their...

For complete story visit theheart.org.
Categories: SICP News

Apixaban cuts stroke risk in all types of AF, says ARISTOTLE

Heartwire News - Wed, 05/16/2012 - 09:30
The trial also had something to say about the degree of stroke risk according to type of atrial fibrillation—that is, whether paroxysmal or permanent/persistent.

For complete story visit theheart.org.
Categories: SICP News

Cancer Survivors Unite for 25th Annual National Cancer Survivors Day Celebration

Mayo Clinic Test - Tue, 05/15/2012 - 16:51
The 25th annual National Cancer Survivors Day event in Rochester, Minn., will be held on Sunday, June 3, 2012. The event is sponsored by Mayo Clinic Cancer Center and the American Cancer Society.
Categories: SICP News

FDA panel recommends lorcaserin for obesity

Heartwire News - Tue, 05/15/2012 - 15:45
The Endocrinologic and Metabolic Drugs Advisory Committee of the FDA has recommended approval of lorcaserin to treat obesity in certain populations.

For complete story visit theheart.org.
Categories: SICP News

William O'Neill goes home to lead new structural heart group at Henry Ford

Heartwire News - Tue, 05/15/2012 - 13:45
Dr William O'Neill is moving from Miami to Detroit to lead a new center for structural heart disease at Henry Ford Hospital.

For complete story visit theheart.org.
Categories: SICP News

TAVI to treat surgical valve failure shows potential, with caveats

Heartwire News - Tue, 05/15/2012 - 13:00
The largest series to date looking at use of a transcatheter valve to treat the failure of a surgically implanted prosthetic has found high rates of survival at one year, but enough in the way of...

For complete story visit theheart.org.
Categories: SICP News

Mayo Clinic Sets Industry Standard for Mobile Experience: Personal, Portable and Participatory

Mayo Clinic Test - Tue, 05/15/2012 - 12:57
Mayo Clinic has created a comprehensive mobile health application, combining a custom mobile experience with unparalleled expertise and access.
Categories: SICP News

Radiology: Contrast-enhanced US could cut EVAR follow-up risks

CardioVascular Business - Tue, 05/15/2012 - 11:39
Contrast-enhanced ultrasound may complement CT angiography surveillance of patients following endovascular repair of abdominal aortic aneurysms (EVAR) and help curb the risk of kidney toxicity, according to a study published online May 15 in Radiology.
Categories: SICP News

Resuscitation rates in out-of-hospital arrests are woeful

Heartwire News - Tue, 05/15/2012 - 11:30
Resuscitation rates in out-of hospital cardiac arrest are woefully low, new US research finds, fueled by poor use of bystander CPR and AED employment, which does show some variability according to...

For complete story visit theheart.org.
Categories: SICP News
Syndicate content